Randomised trial of sequential versus concurrent chemo-radiotherapy in patients with inoperable non-small cell lung cancer (EORTC 08972-22973)-Reference-Cited by-同舟云学术

Randomised trial of sequential versus concurrent chemo-radiotherapy in patients with inoperable non-small cell lung cancer (EORTC 08972-22973)

Published:2007-01 Issue:1 Volume:43 Page:114-121
ISSN:0959-8049
Container-title:European Journal of Cancer
language:en
Short-container-title:European Journal of Cancer

Author:

Belderbos José,Uitterhoeve Lon,van Zandwijk Nico,Belderbos Huub,Rodrigus Patrick,van de Vaart Paul,Price Allan,van Walree Nico,Legrand Catherine,Dussenne Sonia,Bartelink Harry,Giaccone Giuseppe,Koning Caro

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference26 articles.

1. A randomised phase III study of accelerated or standard fraction radiotherapy with or without concurrent carboplatin in inoperable non-small cell lung cancer: final report of an Australian multi-centre trial;Ball;Radiother Oncol,1999

2. The combined use of radiotherapy and chemotherapy in the treatment of solid tumours;Bartelink;Eur J Cancer,2002

3. Phase III Study of the Eastern Cooperative Oncology Group (ECOG 2597): Induction Chemotherapy Followed by Either Standard Thoracic Radiotherapy or Hyperfractionated Accelerated Radiotherapy for Patients With Unresectable Stage IIIA and B Non–Small-Cell Lung Cancer

4. Radiosensitization with carboplatin for patients with unresectable stage III non-small-cell lung cancer: a phase III trial of the Cancer and Leukemia Group B and the Eastern Cooperative Oncology Group;Clamon;J Clin Oncol,1999

5. Gemzar platinum combinations: phase III trials in non-small cell lung cancer;Crino;Lung Cancer,2002

Cited by 162 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Neue radioonkologische Therapiekonzepte beim nicht metastasierten Lungenkarzinom;Zentralblatt für Chirurgie - Zeitschrift für Allgemeine, Viszeral-, Thorax- und Gefäßchirurgie;2024-08

2. Efficiency of moderately hypofractionated radiotherapy in NSCLC cell model;Frontiers in Oncology;2024-04-24

3. Accelerated Hypofractionated Chemoradiation Followed by Stereotactic Ablative Radiotherapy Boost for Locally Advanced, Unresectable Non–Small Cell Lung Cancer;JAMA Oncology;2024-03-01

4. Hypofractionation for Lung Tumors (Primary Malignant, Secondary Malignant);Hypofractionated and Stereotactic Radiation Therapy;2024

5. Severe radiation-induced lymphopenia during concurrent chemoradiotherapy for stage III non-small cell lung cancer: external validation of two prediction models;Frontiers in Oncology;2023-11-09